HTX-001

Asset

Antisense oligonucleotide targeting WISPER long noncoding RNA to reduce cardiac fibrosis.

Stage
Phase 1
Modality
Oligonucleotide
Target
WISPER
1
Indication
1
Trial
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Trials1
  • Signals2

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets